r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

SS

Shehnaaz Suliman

Insider · Director · TXG

Shehnaaz Suliman files insider transactions with the SEC as a director of 10x Genomics (TXG). We hold 3 disclosed purchases and sales filed since 3 August 2017, 2 of them in the last 90 days.

  • Files forTXG
  • Disclosed buys and sells3 in all, 2 in the last 90 days
  • Last disclosure26 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 16 September 2019 — 24 August 2026Director · 10x Genomics (TXG)16 Form 4 lines · source: SEC Form 4
  • Filed 30 January 2019 — 18 May 2026Director · Ultragenyx Pharmaceutical (RARE)18 Form 4 lines · source: SEC Form 4
  • Filed 1 January 2020 — 13 December 2021President and COO · Alector (ALEC)21 Form 4 lines · source: SEC Form 4
  • Filed 1 August 2017 — 20 February 2019SVP, Corp Dev & Strategy · Theravance Biopharma (TBPH)6 Form 4 lines · source: SEC Form 4

Everything they disclosed

61 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.